These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
332 related items for PubMed ID: 10356320
1. Solution structure of the SH2 domain of Grb2 complexed with the Shc-derived phosphotyrosine-containing peptide. Ogura K, Tsuchiya S, Terasawa H, Yuzawa S, Hatanaka H, Mandiyan V, Schlessinger J, Inagaki F. J Mol Biol; 1999 Jun 11; 289(3):439-45. PubMed ID: 10356320 [Abstract] [Full Text] [Related]
2. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor. Nioche P, Liu WQ, Broutin I, Charbonnier F, Latreille MT, Vidal M, Roques B, Garbay C, Ducruix A. J Mol Biol; 2002 Feb 01; 315(5):1167-77. PubMed ID: 11827484 [Abstract] [Full Text] [Related]
3. Thermodynamic and structural analysis of phosphotyrosine polypeptide binding to Grb2-SH2. McNemar C, Snow ME, Windsor WT, Prongay A, Mui P, Zhang R, Durkin J, Le HV, Weber PC. Biochemistry; 1997 Aug 19; 36(33):10006-14. PubMed ID: 9254595 [Abstract] [Full Text] [Related]
4. Nuclear magnetic resonance solution structure of the growth factor receptor-bound protein 2 Src homology 2 domain. Thornton KH, Mueller WT, McConnell P, Zhu G, Saltiel AR, Thanabal V. Biochemistry; 1996 Sep 10; 35(36):11852-64. PubMed ID: 8794768 [Abstract] [Full Text] [Related]
5. Correlation between dynamics and high affinity binding in an SH2 domain interaction. Kay LE, Muhandiram DR, Farrow NA, Aubin Y, Forman-Kay JD. Biochemistry; 1996 Jan 16; 35(2):361-8. PubMed ID: 8555205 [Abstract] [Full Text] [Related]
6. Conformation of an Shc-derived phosphotyrosine-containing peptide complexed with the Grb2 SH2 domain. Ogura K, Tsuchiya S, Terasawa H, Yuzawa S, Hatanaka H, Mandiyan V, Schlessinger J, Inagaki F. J Biomol NMR; 1997 Oct 16; 10(3):273-8. PubMed ID: 9390405 [Abstract] [Full Text] [Related]
7. Potent inhibition of Grb2 SH2 domain binding by non-phosphate-containing ligands. Yao ZJ, King CR, Cao T, Kelley J, Milne GW, Voigt JH, Burke TR. J Med Chem; 1999 Jan 14; 42(1):25-35. PubMed ID: 9888830 [Abstract] [Full Text] [Related]
8. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase. Siegal G, Davis B, Kristensen SM, Sankar A, Linacre J, Stein RC, Panayotou G, Waterfield MD, Driscoll PC. J Mol Biol; 1998 Feb 20; 276(2):461-78. PubMed ID: 9512716 [Abstract] [Full Text] [Related]
9. Crystal structure of the SH2 domain from the adaptor protein SHC: a model for peptide binding based on X-ray and NMR data. Mikol V, Baumann G, Zurini MG, Hommel U. J Mol Biol; 1995 Nov 17; 254(1):86-95. PubMed ID: 7473762 [Abstract] [Full Text] [Related]
10. Structural basis for the high affinity of amino-aromatic SH2 phosphopeptide ligands. Rahuel J, García-Echeverría C, Furet P, Strauss A, Caravatti G, Fretz H, Schoepfer J, Gay B. J Mol Biol; 1998 Jun 19; 279(4):1013-22. PubMed ID: 9642078 [Abstract] [Full Text] [Related]
11. The amino-terminal Src homology 2 domain of phospholipase C gamma 1 is essential for TCR-induced tyrosine phosphorylation of phospholipase C gamma 1. Stoica B, DeBell KE, Graham L, Rellahan BL, Alava MA, Laborda J, Bonvini E. J Immunol; 1998 Feb 01; 160(3):1059-66. PubMed ID: 9570517 [Abstract] [Full Text] [Related]
12. Macrocyclization in the design of Grb2 SH2 domain-binding ligands exhibiting high potency in whole-cell systems. Wei CQ, Gao Y, Lee K, Guo R, Li B, Zhang M, Yang D, Burke TR. J Med Chem; 2003 Jan 16; 46(2):244-54. PubMed ID: 12519063 [Abstract] [Full Text] [Related]
13. Utilization of a beta-aminophosphotyrosyl mimetic in the design and synthesis of macrocyclic Grb2 SH2 domain-binding peptides. Lee K, Zhang M, Liu H, Yang D, Burke TR. J Med Chem; 2003 Jun 19; 46(13):2621-30. PubMed ID: 12801226 [Abstract] [Full Text] [Related]
14. Solution structure and dynamics of G1TE, a nonphosphorylated cyclic peptide inhibitor for the Grb2 SH2 domain. Lou YC, Lung FD, Pai MT, Tzeng SR, Wei SY, Roller PP, Cheng JW. Arch Biochem Biophys; 1999 Dec 15; 372(2):309-14. PubMed ID: 10600169 [Abstract] [Full Text] [Related]
15. Solution structure of the SH2 domain of Grb2/Ash complexed with EGF receptor-derived phosphotyrosine-containing peptide. Tsuchiya S, Ogura K, Hatanaka H, Nagata K, Terasawa H, Mandiyan V, Schlessinger J, Aimoto S, Ohta H, Inagaki F. J Biochem; 1999 Jun 15; 125(6):1151-9. PubMed ID: 10348919 [Abstract] [Full Text] [Related]
16. Dual specificity of Src homology 2 domains for phosphotyrosine peptide ligands. Gay B, Furet P, García-Echeverría C, Rahuel J, Chène P, Fretz H, Schoepfer J, Caravatti G. Biochemistry; 1997 May 13; 36(19):5712-8. PubMed ID: 9153411 [Abstract] [Full Text] [Related]
17. Design and synthesis of conformationally constrained Grb2 SH2 domain binding peptides employing alpha-methylphenylalanyl based phosphotyrosyl mimetics. Oishi S, Karki RG, Kang SU, Wang X, Worthy KM, Bindu LK, Nicklaus MC, Fisher RJ, Burke TR. J Med Chem; 2005 Feb 10; 48(3):764-72. PubMed ID: 15689160 [Abstract] [Full Text] [Related]